Evidence map›Paper›PMID 38703202›Full record

ArticleBioprocess and biosystems engineering2024

Hybrid modeling of an ultracentrifugation process for separation of full and empty adeno-associated virus particles.

Riccardo De-Luca, Miguel Pupo-Correia, Michael Feldhofer, Duarte L Martins, Alexandra Umprecht, Ali Shahmohammadi, Daniel Corona, Moritz von Stosch

Abstract read
In one paragraph

Article in Bioprocess and biosystems engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Riccardo De-LucaDataHow AG, Hagenholzstrasse 111, 8050, Zurich, Switzerland.
Miguel Pupo-CorreiaDataHow Soluções de Inteligência Artificial, Unipessoal, LDA, Rua Filipe Folque 2, 1050-110, Lisbon, Portugal.
Michael FeldhoferBaxalta Innovations GmbH, a Takeda Company, Industriestraße 67, 1221, Vienna, Austria.
Duarte L MartinsBaxalta Innovations GmbH, a Takeda Company, Industriestraße 67, 1221, Vienna, Austria.
Alexandra UmprechtBaxalta Innovations GmbH, a Takeda Company, Industriestraße 67, 1221, Vienna, Austria.
Ali ShahmohammadiTakeda Manufacturing U.S.A., Inc., 95 Hayden Avenue, Lexington, 02421, USA.
Daniel CoronaDataHow Soluções de Inteligência Artificial, Unipessoal, LDA, Rua Filipe Folque 2, 1050-110, Lisbon, Portugal.
Moritz von StoschDataHow AG, Hagenholzstrasse 111, 8050, Zurich, Switzerland. m.vonstosch@datahow.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ultracentrifugation is an attractive method for separating full and empty capsids, exploiting their density difference. Changes of the serotype/capsid, density of loading material, or the genetic information contained in the adeno-associated viruses (AAVs) require the adaptation of the harvesting parameters and the density gradient loaded onto the centrifuge. To streamline these adaptations, a mathematical model could support the design and testing of operating conditions.Here, hybrid models, which combine empirical functions with artificial neural networks, are proposed to describe the separation of full and empty capsids as a function of material and operational parameters, i.e., the harvest model. In addition, critical quality attributes are estimated by a quality model which is operating on top of the harvest model. The performance of these models was evaluated using test data and two additional blind runs. Also, a "what-if" analysis was conducted to investigate whether the models' predictions align with expectations.It is concluded that the models are sufficiently accurate to support the design of operating conditions, though the accuracy and applicability of the models can further be increased by training them on more specific data with higher variability.

Indexed as

DependovirusUltracentrifugationNeural Networks, ComputerVirionAAVFull/empty capsidsHybrid modelUltracentrifugation

Identifiers

PMID38703202
PMCPMC11101501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.